Lv1
10 积分 2025-08-17 加入
Refining the impact of genetic evidence on clinical success
4小时前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
17天前
已完结
An agentic system for rare disease diagnosis with traceable reasoning
3个月前
已完结
Exploring the next generation of antibody–drug conjugates
3个月前
已完结
RNAi-based drug design: considerations and future directions
4个月前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
5个月前
已完结
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
5个月前
已完结
In vivo CAR engineering for immunotherapy
5个月前
已完结
Deep generative models design mRNA sequences with enhanced translational capacity and stability
8个月前
已完结
Supercoiled DNA percentage, a key in-process control of linear DNA template for mRNA drug substance manufacturing
9个月前
已关闭
皖公网安备34019202002308
